De Novo Biosynthesis and Radiolabeling of Mammalian Digitalis-Like Factors

Clinical Chemistry

Volumn 50, Issue 3, 2004, Pages 612-620

  Qazzaz, Hassan M A M ^a   Cao, Zhimin ^a,b   Bolanowski, Duane D ^a   Clark, Barbara J ^a   Valdes Jr , Roland ^a  

^a University of Louisville School of Medicine   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; ACETIC ACID; CARBON 14; CHOLESTEROL; COMPACTIN; CYCLIC AMP DERIVATIVE; DIGITALIS LIKE FACTOR; DIGOXIN; DIHYDRODIGOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROGESTERONE; SUGAR; SULFOSALICYLIC ACID;

ADRENAL CORTEX TUMOR; ANIMAL CELL; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DEGLYCOSYLATION; IMMUNOASSAY; ISOLATION PROCEDURE; ISOTOPE LABELING; MAMMAL; MOLECULE; MOUSE; NONHUMAN; PRECURSOR; PROGESTERONE SYNTHESIS; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RADIOACTIVITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; STEROIDOGENESIS; STIMULATION; STOICHIOMETRY; TISSUE; TUMOR CELL LINE;

ACETIC ACID; ADRENAL CORTEX; ANIMALS; ANTICHOLESTEREMIC AGENTS; CARBON RADIOISOTOPES; CARDENOLIDES; CELL LINE, TUMOR; CHOLESTEROL; CYCLIC AMP; DIGOXIN; IMMUNOASSAY; ISOTOPE LABELING; LOVASTATIN; MICE; SAPONINS;

DIGITALIS; MAMMALIA;

EID: 1542358869     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.022715     Document Type: Article

References (46)

1. Shaikh IM, Lau BWC, Siegfried BA, Valdes R Jr. Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem 1991;266:13672-8.
2. Qazzaz HMA, Jortani SA, Poole JM, Valdes R Jr. Evidence for the presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissue. Clin Chem 1996;42:270-8.
3. +-ATPase extracellular surface probed with a monoclonal antibody that enhances ouabain binding. J Biol Chem 1992;267: 13694-701.
4. +-ATPase and identification of a new region involved in cardiac glycoside interactions. J Biol Chem 1993;268:22686-94.
5. +-ATPase reveal a possible inhibition mechanism via the cation binding domain. J Biol Chem 1996;271:14176-82.
6. +-ATPase α subunit: site-directed mutagenesis of glutamine-111 to arginine and asparagine-122 to aspartic acid generates a ouabain-resistant enzyme. Biochemistry 1988;27:8400-8.
7. Kaplan JH. Biochemistry of Na,K-ATPase. Annu Rev Biocheri 2002;71:511-35.
8. Doris PA, Bagrov AY. Endogenous sodium pump inhibits and blood pressure regulation: an uptake on recent progress. Proc Soc Exo Biol Med 1998;218:156-7.
9. Hollenberg NK, Graves SW. Endogenous sodium pump inhibition: current status and therapeutic opportunities. Prog Drug Res 1996;46:9-42.
10. Valdes R Jr, Graves SW. Protein binding of endogenous digoxin-immunoreactive factors in human serum and its variation with clinical condition. J Clin Endocrinol Metab 1985;60:1135-43.
11. Antolovic R, Kost H, Mohadjerani M, Linder D, Linder M, Schoner WA. Specific binding protein for cardiac glycosides exists in bovine serum. J Biol Chem 1998;273:16259-64.
12. Antolovic R, Bauer N, Mohadjerani M, Kost H, Neu H, Kirch U, et al. Endogenous ouabain and its binding protein: effects of physical exercise and study on the globulin's tissue distribution. Hypertens Res 2000;23:S93-8.
13. Parhami-Seren B, Haberly R, Margolies MN, Haupert GT Jr. Ouabain-binding protein(s) from human plasma. Hypertension 2002;40:220-8.
14. Rose AM, Valdes R Jr. Understanding the sodium pump and its relevance to disease. Clin Chem 1994;40:1674-85.
15. Blaustein MP. Physiological effects of endogenous ouabain: control of intracellular Ca stores and cell responsiveness. Am J Physiol 1993;264:1367-87.
16. Blaustein MP. Endogenous ouabain: role in the pathogenesis of hypertension. Kidney Int 1996;49:1748-53.
17. Dmitrieva RI, Doris PA. Cardiotonic steroids: potential endogenous sodium pump ligands with diverse function. Exp Biol Med 2002;227:561-9.
18. Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 2002;269:2440-8.
19. Qazzaz HMA, Goudy SL, Valdes R Jr. Deglycosylated products of endogenous digoxin-like immunoreactive factor (DLIF) in mammalian tissue. J Biol Chem 1996;271:8731-7.
20. Qazzaz HMA, Valdes R Jr. Simultaneous isolation of endogenous digoxin-like immunoreactive factor (DLIF), ouabain-like factor (OLF), and deglycosylated congeners from mammalian tissues. Arch Biochem Biophys 1996;328:193-200.
21. Qazzaz HMA, El-Masri MA, Valdes R Jr. Secretion of a lactone- hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphate activity by adrenal cells. Endocrinology 2000; 141:3200-9.
22. Tao Q-F, Hollenberg NK, Price DA, Graves SW. Sodium pump isoform specificity for the digitalis-like factor isolated from human peritoneal dialysis. Hypertension 1997;29:815-21.
23. +-ATPase isoforms. Hypertens Res 2000;23(Suppl):S45-51.
24. Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous α-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 2001;37: 462-6.
25. Manunta P, Hamilton BP, Hamlyn JM. Structure-activity relationships for the hypertenslnogenic activity of ouabain: role of the sugar and lactone ring. Hypertension 2001;37:472-7.
26. +-ATPase by endogenous ouabain-like materials. Proc Soc Exp Biol Med 1994;205:202-12.
27. Resko JA, Norman GD, Niswender GD, Spies HG. The relationship between progestins and gonadotropins during the late luteal phase of the menstrual cycle in rhesus monkeys. Endocrinology 1974;94:128-35.
28. +-pump inhibitors in rat urine and diet. J Biol Chem 1994;269:11972-9.
29. Komiyama Y, Nishimura N, Dong XH, Hirose S, Kosaka C, Masaki H, et al. Liquid chromatography mass spectrometric analysis of ouabaln-like factor in biological fluid. Hypertens Res 2000;23: S21-7.
30. Qazzaz HMA, Lane AN, Valdes R Jr. Structural identification of digoxin-like immunoreactive factors (DLIFs) using NMR spectroscopy. Clin Chem 2003;49(Suppl 6):A130.
31. Heftmann E. Steroid biochemistry. New York: Academic Press, 1970:85-96.
32. Greeff K. Handbook of experimental pharmacology, Vol. 56. Cardiac glycosides, part 1. Berlin: Springer-Verlag, 1981:13-24.
33. Kowal J, Fiedler R. Adrenal cells in tissue culture. I. Assay of steroid products; steroidogenic resposes to peptide hormones. Arch Biochem Biophys 1968;128:406-21.
34. Schimmer BP, Schulz P. The role of cAMP and cAMP-dependent protein kinase in forskolin's actions on Y1 adrenocortical tumor cells. Endocr Res 1985;11:199-209.
35. Wong M, Krolczyk AJ, Schimmer BP. The causal relationship between mutations in cAMP-dependent protein kinase and the loss of adrenocorticotropin- regulated adrenocortical functions. Mol Endocrinol 1992;6:1614-24.
36. Waterman MR, Bischof LJ. Mechanisms of ACTH(cAMP)-dependent transcription of adrenal steroid hydroxylases. Endocr Res 1996;22:615-20.
37. Brown MS, Faust JR, Goldstein JL. Induction of 3-hydroxy-3- methylglutaryl coenzyme a reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 1978;253:1121-8.
38. Hamlyn JM, Lu Z, Manunta P, Ludens JH, Kimura K, Shah JR, et al. Observation on the nature, biosynthesis, secretion, and significance of endogenous ouabain. Clin Exp Hypertens 1998;20:523-33.
39. Hinson JP, Harwood S, Dawnay AB. Release of ouabain-like compound (OLC) from the intact perfused rat adrenal gland. Endocr Res 1998;24:721-4.
40. Beck M, Szalay KS, Nagy GM, Toth M, de Chante R. Production of ouabain by rat adrenocortical cells. Endocr Res 1996;22:845-9.
41. Shah JR, Laredo J, Hamilton BP, Hamlyn JM. Effects of angiotensin II on sodium potassium pumps, endogenous ouabain and aldosterone in bovine zona glomerulosa cells. Hypertension 1999;33:373-7.
42. +-ATPase inhibitor and ouabain. Neurochem Res 1997;22:379-83.
43. Li M, Wong KS, Martin A, Withworth A. Adrenocorticotrophin-induced hypertension in rats. Am J Hypertens 1994;7:59-68.
44. Perrin A, Brasmes B, Chambaz EM, Defaye G. Bovine adrenocortical cells in culture synthesize an ouabain-like compound. Mol Cell Endocrinol 1997;126:7-15.
45. Cao TZ, Qazzaz HMA, Bolanowski DD, El-Masri, MA, Clark BJ, and Valdes R Jr. Ex vivo production of digoxin-like immunoreactive factors (DLIF) by mouse adrenal cortex tumor (Y-1) cells [Abstract]. Clin Chem 1999;45(Suppl 6):A83.
46. Lichestein D, Steinitz M, Gati I, Samuelov S, Deutsch J, Orly J. Biosynthesis of digitalis-like compounds in rat adrenal cells: Hydroxycholesterol as possible precursor. Life Sci 1998;62: 2109-26.